newsValeant announces sale of iNova Pharmaceuticals for $930 million19 June 2017 | By Niamh Marriott (European Pharmaceutical Review)Valeant Pharmaceuticals has entered into an agreement to sell its iNova Pharmaceuticals business for $930 million in cash.